Nashville, TN, United States
MRP, LLC dba Aquabiliti recalls
1 recall recorded since 2018, most recently on 28 December 2023. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)1
Terminated or completed0
Class I (FDA)0
Ongoing Class II Medical devices
- Recall started
- 28 December 2023
- Reason
- The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.
- Distribution
- US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA.
- Initiated
- Voluntary: Firm initiated
- Recall number
- Z-1174-2024
- AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.